GlassScriptPhysician profile
Maruthavanan Ram
NPI 1265478788
$481.71
in general payments reported to CMS, 2019-2025
14 companies · $99.24 in 2025
The $99.24 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $6.92 · 2023: $40.25 · 2024: $102 · 2025: $99.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $143.62 | 2019-2025 | Doc Band |
| Romark Laboratories, Lc | $47.25 | 2019 | |
| Pfizer INC. | $41.44 | 2019 | |
| Kaleo, INC. | $41.02 | 2019 | |
| Merck Sharp & Dohme LLC | $29.39 | 2019 | |
| Tris Pharma INC | $28.99 | 2019 | |
| Ironwood Pharmaceuticals, INC | $24.64 | 2024 | |
| Cipher Pharmaceuticals US LLC | $23.90 | 2025 | Natroba, Spinosad |
| Verrica Pharmaceuticals INC. | $22.77 | 2024 | Ycanth |
| Sanofi-Aventis U.S. LLC | $21.29 | 2025 | |
| Alk-Abello, INC | $20.15 | 2025 | Neffy |
| Sobi, INC | $19.35 | 2019 | |
| Phadia US INC. | $10.98 | 2019 | |
| Quidel Corporation | $6.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maruthavanan Ram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.